Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A offering by Accelerate Diagnostics, Inc. of $150 million aggregate principal amount…
Accelerate Diagnostics, Inc’s $150 Million Convertible Senior Notes Offering
